GPP
TBIO

Great Point Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Great Point Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-943,339
Closed -$12.8M – 47
2020
Q3 		$12.8M Buy
+943,339
New +$14.5M 1.16% 21

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Great Point Partners's TBIO Position: Q4 2020 in Review

Great Point Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q4 2020, closing a stake of 943,339 shares — an estimated $12.8M sold.

Great Point Partners first reported a position in TBIO in Q3 2020 and held it in 1 quarter. The position peaked at $12.8M in Q3 2020. 150 funds tracked by Wall St. Rank hold TBIO as of Q4 2020.

  • Great Point Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Great Point Partners sold 943,339 Translate Bio, Inc. Common Stock shares in Q4 2020, an estimated $12.8M.
  • Great Point Partners first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Great Point Partners's Translate Bio, Inc. Common Stock position peaked at $12.8M in Q3 2020.
  • 150 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q4 2020.

Based on Great Point Partners's 13F filing for Q4 2020, filed 16 Feb 2021.